Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The first description of a singular case of synchronous chronic myelomonocytic leukemia and diffuse large b-cell lymphoma.
Romano A, Giusti M, Di Giorgio M, Lumera G, Laura Parrinello N, Cosentino S, Ippolito M, Villari L, Alberto Palumbo G, Di Raimondo F, Santo Signorelli S. Romano A, et al. Among authors: villari l. Clin Case Rep. 2021 Sep 21;9(9):e03817. doi: 10.1002/ccr3.3817. eCollection 2021 Sep. Clin Case Rep. 2021. PMID: 34589219 Free PMC article.
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma.
Romano A, Parrinello NL, Vetro C, Tibullo D, Giallongo C, La Cava P, Chiarenza A, Motta G, Caruso AL, Villari L, Tripodo C, Cosentino S, Ippolito M, Consoli U, Gallamini A, Pileri S, Di Raimondo F. Romano A, et al. Among authors: villari l. Oncotarget. 2016 Oct 11;7(41):67333-67346. doi: 10.18632/oncotarget.12024. Oncotarget. 2016. PMID: 27637084 Free PMC article.
Increased phospho-mTOR expression in megakaryocytic cells derived from CD34+ progenitors of essential thrombocythaemia and myelofibrosis patients.
Vicari L, Martinetti D, Buccheri S, Colarossi C, Aiello E, Stagno F, Villari L, Cavalli M, Di Raimondo F, Gulisano M, De Maria R, Vigneri P. Vicari L, et al. Among authors: villari l. Br J Haematol. 2012 Oct;159(2):237-40. doi: 10.1111/j.1365-2141.2012.09246.x. Epub 2012 Aug 24. Br J Haematol. 2012. PMID: 22924455 Free article. No abstract available.
Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy.
Leotta S, Pirosa MC, Markovic U, Scalise L, Bulla A, Sapienza G, Di Giorgio MA, Martino EA, Curto Pelle A, Leotta V, Milone G, Cupri A, Vaddinelli D, Villari L, Conticello C, Milone G. Leotta S, et al. Among authors: villari l. Chemotherapy. 2019;64(2):110-114. doi: 10.1159/000502473. Epub 2019 Sep 18. Chemotherapy. 2019. PMID: 31533095
Plerixafor on-demand in association with low-dose cyclophosphamide and G-CSF in the mobilization of patients with multiple myeloma: High effectiveness, low toxicity, and affordable cost.
Milone G, Conticello C, Leotta S, Michieli MG, Martino M, Marco ALD, Spadaro A, Cupri A, Condorelli A, Milone GA, Markovic U, Sciortino R, Schininà G, Moschetti G, Villari L, Saccardi R; for GITMO. Milone G, et al. Among authors: villari l. Leuk Res Rep. 2020 Oct 30;14:100227. doi: 10.1016/j.lrr.2020.100227. eCollection 2020. Leuk Res Rep. 2020. PMID: 33204611 Free PMC article.
Comparison of JAK2V617F -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology.
Latagliata R, Polverelli N, Tieghi A, Palumbo GA, Breccia M, Sabattini E, Villari L, Riminucci M, Valli R, Catani L, Alimena G, Ottaviani E, Fama A, Martinelli G, Perricone M, Spinsanti M, Cavo M, Vianelli N, Palandri F. Latagliata R, et al. Among authors: villari l. Hematol Oncol. 2018 Feb;36(1):269-275. doi: 10.1002/hon.2430. Epub 2017 May 16. Hematol Oncol. 2018. PMID: 28509339
41 results